The USER Study: A Chart Review of Patients Receiving a 0.2 Μg/Day Fluocinolone Acetonide Implant for Diabetic Macular Edema
Ophthalmology and Therapy- United Kingdom
doi 10.1007/s40123-018-0155-5
Full Text
Abstract
Available in
Categories
Date
December 17, 2018
Authors
Publisher
Springer Science and Business Media LLC